Share on LinkedInShare on LinkedIn

ARTICLE · 06 APRIL 2020

USTR Requests Comments On Section 301 Tariffs On COVID-19 Related Products

Akin
Akin
Contributor
Akin

Akin

Akin is a global law firm with more than 1,100 lawyers and advisors who pride themselves on...

View firm profile
Explore more from Akin

Late on Friday, March 20, 2020, USTR announced that it has opened a new public comment period for businesses and government agencies to request additional product exclusions

United StatesInternational Law

Key Points

  • Late on Friday, March 20, 2020, USTR announced that it has opened a new public comment period for businesses and government agencies to request additional product exclusions from Section 301 duties for certain Chinese-origin medical-care products needed to respond to the COVID-19 outbreak.
  • USTR encourages parties to submit comments as promptly as possible, but will keep the comment period open until June 25, 2020, with further extensions as appropriate.
  • Interested parties can provide comments here.

Introduction and Background

Starting in June 2018, the Office of the U.S. Trade Representative (USTR) has implemented duties in four separate tranches (“Lists 1-4”) on billions of dollars of goods imported from China – including roughly $5 billion of medical goods from China – following its investigation into China’s acts, policies and practices related to technology transfer, intellectual property and innovation under Section 301 of the

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from